BioSpace News Archive

Passage Bio, Inc., today announced the pricing of its initial public offering of 12,000,000 shares of common stock at a public offering price of $18.00 per share.

Companion Medical today confirmed that it has received clearance from the FDA for its InPen bolus calculator for fixed dosing and meal estimation

Amgen (NASDAQ:AMGN) will present at the Cowen 40 th Annual Healthcare Conference at 11:20 a.m. ET on Monday, March 2, 2020 in Boston. Peter H. Griffith , executive vice president and chief financial officer, and Murdo Gordon , executive vice president of Global Commercial Operations at Amgen will present.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the company has received a contract from the China Technology Exchange, Beijing Zhonghua Investment Fund Management Co., LTD., Biology Institute of Shandong Academy of Sciences and Sinotek-Advocates International Industry Development (Shenzhen) Co., LTD.

Healthcare IT changemakers will gather in Orlando March 9-13 for HIMSS20, where they’ll find a wealth of knowledge and resources for health information technology needs, all in one place.

BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading life sciences company specializing in perinatal tissue-based allografts, today announced its attendance to the 2020 Perinatal Stem Cell Society Conference.

The American Pharmacists Association submitted comments to the Federal Trade Commission and the U.S. Department of Justice Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice.

NormaTec and the Symetra Tour have announced a new partnership for the 2020 season naming NormaTec the official recovery system of the Symetra Tour.

Cryos USA - International Sperm and Egg Bank, based in Orlando, shared the results of their first ever scientific symposium on Assisted Reproductive Technology (ART) held at the Grand Bohemian hotel on Friday, February 21, 2020

Ubiquitin Conjugating Enzyme serves as key target to BERG’s oncology therapeutics discovery efforts